BlackRock’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-4,444,070
| Closed | -$213M | – | 5115 |
|
|
2020
Q1 | $213M | Sell |
4,444,070
-44,254
| -1% | -$2.12M | 0.01% | 1110 |
|
|
2019
Q4 | $211M | Sell |
4,488,324
-201,668
| -4% | -$9.46M | 0.01% | 1442 |
|
|
2019
Q3 | $111M | Buy |
4,689,992
+630,823
| +16% | +$14.9M | ﹤0.01% | 1826 |
|
|
2019
Q2 | $122M | Buy |
4,059,169
+886,583
| +28% | +$26.7M | 0.01% | 1764 |
|
|
2019
Q1 | $71.1M | Buy |
3,172,586
+527,325
| +20% | +$11.8M | ﹤0.01% | 2075 |
|
|
2018
Q4 | $48.1M | Buy |
2,645,261
+595,328
| +29% | +$10.8M | ﹤0.01% | 2259 |
|
|
2018
Q3 | $37.1M | Buy |
2,049,933
+512,602
| +33% | +$9.27M | ﹤0.01% | 2527 |
|
|
2018
Q2 | $15.3M | Buy |
1,537,331
+385,587
| +33% | +$3.84M | ﹤0.01% | 2990 |
|
|
2018
Q1 | $6.12M | Buy |
1,151,744
+199,164
| +21% | +$1.06M | ﹤0.01% | 3323 |
|
|
2017
Q4 | $8.1M | Buy |
952,580
+308,452
| +48% | +$2.62M | ﹤0.01% | 3218 |
|
|
2017
Q3 | $9.41M | Buy |
644,128
+22,799
| +4% | +$333K | ﹤0.01% | 3153 |
|
|
2017
Q2 | $11.6M | Buy |
621,329
+276,288
| +80% | +$5.18M | ﹤0.01% | 3049 |
|
|
2017
Q1 | $7.35M | Buy |
345,041
+327,934
| +1,917% | +$6.98M | ﹤0.01% | 3219 |
|
|
2016
Q4 | $260K | Buy |
+17,107
| New | +$260K | ﹤0.01% | 1930 |
|